This is not the most recent version of the article. View current version (29 JUN 2013)

Intervention Review

Maintenance chemotherapy for ovarian cancer

  1. Ling Mei1,
  2. Hui Chen1,
  3. Dong Mei Wei1,
  4. Fang Fang1,*,
  5. Guan J Liu2,
  6. Huan Yu Xie3,
  7. Xun Wang1,
  8. Juan Zou1,
  9. Xu Han1,
  10. Dan Feng1

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 8 SEP 2010

Assessed as up-to-date: 4 AUG 2010

DOI: 10.1002/14651858.CD007414.pub2


How to Cite

Mei L, Chen H, Wei DM, Fang F, Liu GJ, Xie HY, Wang X, Zou J, Han X, Feng D. Maintenance chemotherapy for ovarian cancer. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD007414. DOI: 10.1002/14651858.CD007414.pub2.

Author Information

  1. 1

    West China Second Hospital, Sichuan University, Gynecology & Obstetrics Department, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, Chengdu, Sichuan, China

  3. 3

    People's Hospital of Deyang City, Gynecology & Obstetrics Department, Deyang, Sichuan, China

*Fang Fang, Gynecology & Obstetrics Department, West China Second Hospital, Sichuan University, Clinical Medicine Dept of Sichuan University, Chengdu, Sichuan, 610041, China. fangf59@yahoo.com.cn.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 SEP 2010

SEARCH

This is not the most recent version of the article. View current version (29 JUN 2013)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    MCA Wouters, EM Dijkgraaf, ML Kuijjer, ES Jordanova, H Hollema, MJP Welters, JJM van der Hoeven, T Daemen, JR Kroep, HW Nijman, SH van der Burg, Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer, OncoImmunology, 2014, 3, 12, e962397

    CrossRef

  2. 2
    C. William Helm, Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer, Surgical Oncology Clinics of North America, 2012, 21, 4, 645

    CrossRef

  3. 3
    Marie-Anne Smit, John L. Marshall, Maintenance therapy in solid tumors, Community Oncology, 2012, 9, 8, 247

    CrossRef

  4. 4
    Ling Mei, Hui Chen, Fuxia Chen, Dan Feng, Fang Fang, Maintenance bioimmunotherapy for epithelial ovarian cancer, The Cochrane Library,
  5. 5
    Ling Mei, Hui Chen, Dong Mei Wei, Fang Fang, Guan J Liu, Huan Yu Xie, Xun Wang, Juan Zou, Xu Han, Dan Feng, Maintenance chemotherapy for ovarian cancer, The Cochrane Library,